INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![map-medicine-global-GettyImages-1263783932]( "The Asia Advantage: Why US Biotechs Should Look East For Clinical Trials")
The Asia Advantage: Why US Biotechs Should Look East For Clinical TrialsExplore the compelling reasons behind the Asia Advantage and highlights how Avance Clinical's strategic expansion into the region supports biotechs in maximizing these benefits.
-
![New Purpose-Built Facility]( "New Purpose-Built Facility For Large-Scale Sterile Fill/Finish Operations")
New Purpose-Built Facility For Large-Scale Sterile Fill/Finish OperationsExpanding capacity for late-phase clinical and large-scale commercial small molecule and biologic drugs, a new facility boosts sterile fill/finish capabilities.
-
![GettyImages-487610898 Vendors]( "Why Settle For Good Enough On The \"Easy\" Stuff?")
Why Settle For Good Enough On The "Easy" Stuff?High-stakes expertise shouldn’t be reserved for complex trials. Applying strategic support early helps prevent inefficiencies, delays, and missed opportunities.
-
![data analytics team meeting-GettyImages-2166193783]( "Paperless Online Remote Source Document Verification")
Paperless Online Remote Source Document VerificationLearn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.
-
Maximize Your DHT Investment With ActiGraph Scientific Services2/16/2024
Discover how the ActiGraph Science Team collaborates closely with study teams to capture meaningful clinical outcomes remotely and continuously using sensor-based Digital Health Technologies.
-
Quotient Sciences Capacity Update July 20257/29/2025
Explore how expedited review pathways can be strategically used to accelerate development while mitigating CMC risks.
-
De-Risking FIH: Integrated Strategies For Rapid Proof-Of-Concept12/17/2025
Proper planning for first-in-human studies is crucial to successful drug development, which requires innovative trial designs and sound CMC strategies to mitigate risk and expedite proof-of-concept.
-
AI-Powered Strategy Is Redefining Patient Recruitment Performance9/9/2025
This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.
-
Metabolic Disorders Clinical Trial Case Study9/17/2024
Check out this case study to learn how partnering with an accomplished contract research organization is essential in the complex and dynamic field of metabolic drug development.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![CROs & CMOs Evolving Intelligence: Enhance Performance With Corporate Libraries]( "7 Reasons CROs Should Work With Sikich And SuiteSuccess")
When you engage with Sikich to implement NetSuite and SuiteSuccess for CROs, you can rely on the industry and technical experience of a successful consultancy with many loyal, satisfied clients.
-
![GettyImages-1316437398-planning-strategy-data]( "Proper Data Management Across All Areas & Phases")
Get extensive experience developing and delivering quality services for data management departments across all major therapeutic areas and phases for pharma/biotech companies.
-
![connections people]( "Patient Focused, Data Empowered, Delivery Driven")
Biorasi solves the problem of patient access and engagement with data empowered insights and operational excellence, delivering faster, higher quality trials.
-
![GettyImages-681726866 patient, payment, reimbursement]( "Why Fee-Free Trial Participant Payments Always Pay Off")
Remove the administrative burden of clinical trials for patients while ensuring compliance and offering global accessibility.
-
![files iStock-1277601366.jpg]( "eTMF: Promising Accessibility, Compliance, And More")
Our model combines the depth and experience level of our people with effective tools and processes already in place that are designed to ensure your critical eTMF documents and content are secure, organized, readily accessible, and always in complete compliance with all relevant regulations.
